drugset / Trial / NCT01547000
Guanfacine in Children With Tic Disorders
Phase 4
Completed
34 enrolled
Yale University
Icahn School of Medicine at Mount Sinai · collabNew York University · collabShire · collabUniversity of South Florida · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this pilot study is to obtain preliminary information on the tolerability and efficacy of extended release guanfacine (trade name Intuniv) in children with Tourette Disorder (TD, also called Tourette syndrome).
Timeline
- Start
- 2012-04
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 4 mg | — |